Melinta Therapeutics announces proposed offering of common stock
Melinta Therapeutics announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $75,000,000. All of the shares of the common stock to be sold in the offering are to be sold by Melinta. May 21, 2018